Détail de la notice
Titre du Document
Folic acid, inflammation, and atherosclerosis : False hopes or the need for better trials?
Auteur(s)
MANGONI Arduino A.
Résumé
An increasing body of evidence supports the existence of a strong link between inflammation, endothelial dysfunction, and the onset and progression of atherosclerosis. However, a cause-effect relationship between these phenomena has not been demonstrated yet. Although some inflammatory markers, such as C-reactive protein, have been recently shown to improve risk stratification and to strongly predict cardiovascular outcome, it is largely unknown whether modifications of these markers might provide salutary effects and reduce cardiovascular morbidity and mortality. The B-vitamin folic acid has recently gained attention because of its potential to provide beneficial effects on surrogate end-points, such as endothelial function, in patients at high cardiovascular risk. However, the role of folic acid in mitigating the pro-inflammatory state associated with atherosclerosis is controversial. Despite the theoretical arguments supporting the potential anti-atherosclerotic and anti-inflammatory effects of folic acid, the current evidence is limited, deriving from small trials on different study populations, using folic acid often in combination with other vitamins and for different treatment periods. This review will consider the current evidence supporting the role of some well-established inflammatory markers in predicting cardiovascular outcomes, the mechanisms by which folic acid might exert anti-inflammatory effects, the epidemiological data relating folic acid concentrations wi
Editeur
Elsevier
Identifiant
PMID : 16413521 ISSN : 0009-8981 CODEN : CCATAR
Source
Clinica chimica acta (Print) A. 2006, vol. 367, n° 1-2, pp. 11-19 [9 pages]
Langue
Anglais
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :